[PMID: 41640113] PubMed record related to this compound for laboratory literature review
Understanding what happens when you stop semaglutide and how to taper off tirzepatide properly helps prevent rebound weight gain
To assess the association of semaglutide with incident CUD, the study population included 587,849 patients with T2D who had active medical encounters for T2D during 12/20175/2021, were for the first time prescribed semaglutide (Ozempic) or non-GLP1-1RA anti-diabetes medications (new-user design) during 12/20175/2021(index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
139 LiH.ZhaoJ.LaiL.XiaY.WanC.WeiS.et al (2022)
Clean the injection site Using an alcohol swab, clean the injection site thoroughly